MGUS prevalence in a cohort of AML patients-Reference-Cited by-同舟云学术

MGUS prevalence in a cohort of AML patients

Published:2013-07-11 Issue:2 Volume:122 Page:294-295
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Wu S. Peter¹,Costello Rene¹,Hofmann Jonathan N.²,Korde Neha¹,Mailankody Sham¹,Purdue Mark²,Landgren Ola¹

Affiliation:

1. Multiple Myeloma Section, Metabolism Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD

2. Occupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/122/2/294/1371076/294.pdf

Reference13 articles.

1. Multiple Myeloma I. The Pathogenesis of “Amyloidosis.;Osserman;Semin Hematol,1964

2. Multiple myeloma and acute myelomonocytic leukemia.;Kyle;N Engl J Med,1970

3. Multiple myeloma and acute leukemia associated with alkylating agents.;Kyle;Arch Intern Med,1975

4. The chemotherapy on plasma-cell myeloma and the incidence of acute leukemia.;Bergsagel;N Engl J Med,1979

5. A comparison of the incidence of the myelodysplastic syndrome and acute myeloid leukaemia following melphalan and cyclophosphamide treatment for myelomatosis. A report to the Medical Research Council’s working party on leukaemia in adults.;Cuzick;Br J Cancer,1987

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Co-existence of myeloid neoplasm and monoclonal gammopathy; case series and review of literature;Hematology/Oncology and Stem Cell Therapy;2018-09

2. Risk of myeloid neoplasms after solid organ transplantation;Leukemia;2014-04-14